| |
| |
|
| Insider
Information: |
Digiandomenico Anthony |
| Relationship: |
Director |
| City: |
Denver |
| State: |
CO |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
2,193,566 |
|
|
Indirect Shares
|
3,000 |
|
|
| Direct
Value |
$13,118,617 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,196,566 |
|
|
| Total
Value |
$13,118,617 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
3
|
0
|
|
Stock
price went up :
|
3
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
3.0
|
0.0
|
| Percentage
Gain/Loss : |
 216.4%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
True Drinks Holdings Inc |
TRUU |
|
2012-08-27 |
1,368,132 |
|
0 |
Premium* |
|
|
Medivation Inc |
MDVN |
Director |
2004-12-17 |
145,288 |
2004-12-17 |
3,000 |
Premium* |
|
|
Endra Life Sciences Inc. |
NDRA |
Director |
2023-05-02 |
102,434 |
2017-05-12 |
0 |
Premium* |
|
|
Provention Bio Inc |
PRVB |
Director |
2019-12-03 |
520,712 |
2018-11-26 |
0 |
Premium* |
|
|
Cue Biopharma, Inc. |
CUE |
Director |
2018-12-28 |
57,000 |
2018-12-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2023-05-02 |
4 |
B |
$1.20 |
$100,000 |
D/D |
83,333 |
102,434 |
2.39 |
- |
|
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2020-07-21 |
4 |
OE |
$0.87 |
$87,438 |
D/D |
100,503 |
382,012 |
0 |
- |
|
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2020-06-08 |
4 |
B |
$0.92 |
$4,600 |
D/D |
5,000 |
281,509 |
2.31 |
% |
|
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2020-05-28 |
4 |
B |
$0.90 |
$4,500 |
D/D |
5,000 |
276,509 |
2.31 |
% |
|
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2020-05-22 |
4 |
B |
$0.78 |
$7,800 |
D/D |
10,000 |
252,083 |
2.39 |
% |
|
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2020-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
42,857 |
242,083 |
0 |
- |
|
| NDRA |
Endra Life Sciences Inc. |
Director |
– • – |
2019-12-11 |
4 |
A |
$0.87 |
$87,438 |
D/D |
100,503 |
199,226 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-12-03 |
4 |
A |
$0.00 |
$0 |
D/D |
342,000 |
520,712 |
0 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-09-30 |
4 |
B |
$6.83 |
$204,900 |
D/D |
30,000 |
178,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-09-26 |
4 |
B |
$8.44 |
$42,200 |
D/D |
5,000 |
148,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-09-25 |
4 |
B |
$8.39 |
$41,950 |
D/D |
5,000 |
143,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-08-08 |
4 |
B |
$9.09 |
$90,900 |
D/D |
10,000 |
138,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-06-20 |
4 |
B |
$10.96 |
$109,600 |
D/D |
10,000 |
128,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-06-18 |
4 |
B |
$10.88 |
$108,800 |
D/D |
10,000 |
118,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2019-06-17 |
4 |
B |
$12.16 |
$304,000 |
D/D |
25,000 |
108,712 |
2.39 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Director |
– • – |
2018-12-28 |
4 |
B |
$4.62 |
$32,340 |
D/D |
7,000 |
57,000 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2018-12-28 |
4 |
B |
$1.76 |
$17,600 |
D/D |
10,000 |
83,712 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2018-12-27 |
4 |
B |
$1.95 |
$39,000 |
D/D |
20,000 |
73,712 |
2.39 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Director |
– • – |
2018-12-27 |
4 |
B |
$4.77 |
$95,400 |
D/D |
20,000 |
50,000 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2018-12-24 |
4 |
B |
$1.92 |
$33,158 |
D/D |
17,270 |
53,712 |
2.39 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Director |
– • – |
2018-12-24 |
4 |
B |
$4.81 |
$48,100 |
D/D |
10,000 |
30,000 |
2.39 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Director |
– • – |
2018-12-21 |
4 |
B |
$4.49 |
$44,900 |
D/D |
10,000 |
20,000 |
2.39 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2018-12-21 |
4 |
B |
$1.85 |
$3,700 |
D/D |
2,000 |
36,442 |
2.31 |
- |
|
| PRVB |
Provention Bio Inc |
Director |
– • – |
2018-12-20 |
4 |
B |
$1.96 |
$9,800 |
D/D |
5,000 |
34,442 |
2.39 |
- |
|
| CUE |
Cue Biopharma, Inc. |
Director |
– • – |
2018-12-17 |
4 |
B |
$5.48 |
$54,800 |
D/D |
10,000 |
10,000 |
2.39 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
